Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on April 4, 2025
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
GlobeNewswire
·
April 4, 2025
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Beyond Oil Announces Distribution Agreement in the Netherlands with Mandarin Food Products
GlobeNewswire
·
April 4, 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, April 04, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company dedicated to reducing health risks associated with fried …
Eros Resources Closes Oversubscribed $2.1 million Private Placement Financing
GlobeNewswire
·
April 4, 2025
Vancouver, BC, April 04, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV: ROCK) (OTCQB: EROSF) (“Eros” or the “Company”) is pleased to announce the closing of its private placement of C$2,077,500 (the "Financing"), which represents an oversubscription …
Far Niente Steps Up to the Plate as Proud Partner of the San Francisco Giants
GlobeNewswire
·
April 4, 2025
Oakville, CA, April 04, 2025 (GLOBE NEWSWIRE) -- Far Niente Wine Estates, one of Napa Valley’s most venerated wine houses, is delighted to announce it will bring its portfolio to Oracle Park as a proud partner of the San Francisco Giants. Beginning this …
Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan
GlobeNewswire
·
April 4, 2025
BAODING, China, April 05, 2025 (GLOBE NEWSWIRE) -- European Wellness Biomedical Group (EWBG), a global pioneer in bioregenerative medicine and wellness innovation, today unveiled new breakthroughs in autism-focused therapies under the leadership of Prof. …
Edesa Biotech Announces Chief Financial Officer Transition
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler …
CubeSmart Announces the Date of Its First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 4, 2025
MALVERN, Pa., April 04, 2025 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced that the Company will release financial results for the three-month period ended March 31, 2025 after the market close on Thursday, May 1, 2025. An accompanying …
Pivotal Helix Wins Gold 2025 Edison Award
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Pivotal, the market leader in light electric vertical takeoff and landing (eVTOL) aircraft, today announced it was recognized with the prestigious Gold 2025 Edison Award in The Future of Personal Flight …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to …
Cipher Mining Announces March 2025 Operational Update
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for March 2025. Key Highlights Key Metrics March 2025 BTC Mined1 210 BTC Sold 206 BTC …
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
GlobeNewswire
·
April 4, 2025
ATHENS, Greece, April 04, 2025 (GLOBE NEWSWIRE) -- TEN Ltd. (“TEN”) (NYSE: TEN) (the “Company”), a leading diversified crude, product and LNG tanker operator, today announced that its Board of Directors declared the regular quarterly cash dividend of …
Artesian Water Company, Inc. Files Application with Delaware Public Service Commission for Increase in Customer Rates
GlobeNewswire
·
April 4, 2025
NEWARK, Del., April 04, 2025 (GLOBE NEWSWIRE) -- Artesian Water Company, Inc. (“Artesian”), a subsidiary of Artesian Resources Corporation (Nasdaq: ARTNA), filed an application with the Delaware Public Service Commission (PSC) today for a change in …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Quest Resource Holding Corporation Finalizes Sale of Non-Core Portion of RWS Business
GlobeNewswire
·
April 4, 2025
THE COLONY, Texas, April 04, 2025 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest” or the “Company”), a national leader in environmental waste and recycling services, today announced the sale of its tenant-direct portion of …
Giga Metals Completes Non-Brokered Private Placement
GlobeNewswire
·
April 4, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 04, 2025 (GLOBE NEWSWIRE) -- Mark Jarvis, CEO of Giga Metals Corp. (TSX.V – GIGA) (“Giga” or the “Company”) announced today that Giga has …